TEVA 5256 (Clindamycin 300 mg)
Pill imprint TEVA 5256 has been identified as Clindamycin hydrochloride 300 mg.
Clindamycin is used in the treatment of bacterial infection; bacterial vaginitis; skin or soft tissue infection; sinusitis; prevention of perinatal group b streptococcal disease (and more), and belongs to the drug class lincomycin derivatives. There is no proven risk in humans during pregnancy. Clindamycin 300 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- 300 mg
- Prescription only
More about clindamycin
- Clindamycin solution
- Clindamycin suspension
- Clindamycin oral/injection
- Clindamycin (Advanced Reading)
- Clindamycin Oral, Injection, Intravenous (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.